EX-99.2 3 q420238-kex992.htm EX-99.2 Document
celogo.jpg
Exhibit 99.2
Non-US GAAP Financial Measures and Supplemental Information
February 20, 2024
In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.
Purpose
The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures. This document is updated quarterly.
Presentation
This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.
Use of Non-US GAAP Financial Measures
From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.
Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Financial Information/Financial Document Library page of our website, investors.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.
Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Financial Information/Financial Document Library page of our website, investors.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.
This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.
Specific Measures Used
This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt
1

celogo.jpg
is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity.
Definitions
Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8). We believe that adjusted EBIT provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of unusual, non-operational or restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations because of the excluded items. Adjusted EBIT is one of the measures management uses for planning and budgeting, monitoring and evaluating financial and operating results and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales. Adjusted EBIT margin has the same uses and limitations as Adjusted EBIT.
Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization. We believe that Operating EBITDA provides transparent and useful information to investors, analysts and other parties in evaluating our operating performance relative to our peer companies. Operating EBITDA margin is defined by the Company as Operating EBITDA divided by net sales. Operating EBITDA margin has the same uses and limitations as Operating EBITDA.
Operating profit (loss) attributable to Celanese Corporation is defined by the Company as operating profit (loss), less earnings (loss) attributable to noncontrolling interests ("NCI"). We believe that operating profit (loss) attributable to Celanese Corporation provides transparent and useful information to management, investors, analysts and other parties in evaluating our core operational performance. Operating margin attributable to Celanese Corporation is defined by the Company as operating profit (loss) attributable to Celanese Corporation divided by net sales. Operating margin attributable to Celanese Corporation has the same uses and limitations as Operating profit (loss) attributable to Celanese Corporation.
Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We believe that adjusted earnings per share provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of the above stated items that affect comparability and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.
2

celogo.jpg
Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our NCI joint ventures. We believe that free cash flow provides useful information to management, investors, analysts and other parties in evaluating the Company's liquidity and credit quality assessment because it provides an indication of the long-term cash generating ability of our business. Although we use free cash flow as a measure to assess the liquidity generated by our business, the use of free cash flow has important limitations, including that free cash flow does not reflect the cash requirements necessary to service our indebtedness, lease obligations, unconditional purchase obligations or pension and postretirement funding obligations. Free cash flow is not a measure of cash available for discretionary expenditures since the Company has certain debt service and finance lease payments that are not deducted from that measure. We do not provide reconciliations for free cash flow on a forward-looking basis when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of items such as working capital changes, fluctuations in foreign currency exchange rates, the impact and timing of potential acquisitions and divestitures, and other structural changes, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
Net debt is defined by the Company as total debt less cash and cash equivalents. We believe that net debt provides useful information to management, investors, analysts and other parties in evaluating changes to the Company's capital structure and credit quality assessment.
Return on invested capital (adjusted) is defined by the Company as adjusted EBIT, tax effected using the adjusted tax rate, divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity. We believe that return on invested capital (adjusted) provides useful information to management, investors, analysts and other parties in order to assess our income generation from the point of view of our stockholders and creditors who provide us with capital in the form of equity and debt and whether capital invested in the Company yields competitive returns.
Supplemental Information
Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:
Net sales for each of our business segments and the percentage increase or decrease in net sales attributable to price, volume, currency and other factors for each of our business segments.
Cash dividends received from our equity investments.
For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside stockholders' interests are shown as NCI. Amounts referred to as "attributable to Celanese Corporation" are net of any applicable NCI.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
3

celogo.jpg
Table 1
Celanese Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22
(In $ millions)
Net earnings (loss) attributable to Celanese Corporation1,960 698 951 220 91 1,894 767 191 434 502 
(Earnings) loss from discontinued operations(1)— 
Interest income(39)(12)(12)(7)(8)(69)(33)(34)(1)(1)
Interest expense720 178 178 182 182 405 168 154 48 35 
Refinancing expense— — — — — — — — 
Income tax provision (benefit)(790)(575)(236)(4)25 (489)(840)127 112 112 
Certain Items attributable to Celanese Corporation (Table 8)
(114)139 (438)54 131 422 239 71 47 65 
Adjusted EBIT1,753 434 451 444 424 2,171 302 510 646 713 
Depreciation and amortization expense(1)
691 174 173 172 172 446 151 97 98 100 
Operating EBITDA2,444 608 624 616 596 2,617 453 607 744 813 
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22
(In $ millions)
Engineered Materials15 15 — — — 13 
Acetyl Chain— — — — — — — — 
Other Activities(2)
— — — — — — — — 
Accelerated depreciation and amortization expense15 15 — — — 16 
Depreciation and amortization expense(1)
691 174 173 172 172 446 151 97 98 100 
Total depreciation and amortization expense706 189 173 172 172 462 153 100 103 106 
______________________________
(1)Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above.
(2)Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
4

celogo.jpg
Table 1a
M&M Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited
2023Q4 '23Q3 '23Q2 '23Q1 '23Q4 '22
(In $ millions)
Net earnings (loss) attributable to M&M24 (22)47 47 (48)(69)(3)
Income tax provision (benefit)65 43 10 (1)13 
Certain Items(1)
151 30 17 18 86 72 
Adjusted EBIT240 51 74 64 51 
Depreciation and amortization expense275 69 70 68 68 47 
Operating EBITDA(2)
515 120 144 132 119 56 (4)
______________________________
(1)Amount is included within total Certain Items shown in Table 8.
(2)Excludes $(22) million, $(19) million, $(23) million, $(23) million and $(17) million of Operating EBITDA included in Other Activities for the three months ended December 31, 2023, September 30, 2023, June 30, 2023, March 31, 2023 and December 31, 2022, respectively.
(3)Excludes $30 million of Net loss for the month ended October 31, 2022, prior to our acquisition of the majority of the Mobility & Materials business ("M&M Business") of DuPont de Nemours, Inc.
(4)Excludes $22 million of Operating EBITDA for the month ended October 31, 2022, prior to our acquisition of the M&M Business.
5

Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited
celogo.jpg
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22
(In $ millions, except percentages)
Operating Profit (Loss) / Operating Margin
Engineered Materials1,083 17.6 %122 8.7 %691 45.2 %158 10.0 %112 6.9 %429 10.7 %25 2.0 %114 12.3 %166 17.5 %124 13.6 %
Acetyl Chain1,109 22.7 %264 22.4 %272 22.3 %295 23.9 %278 22.2 %1,447 25.2 %204 18.0 %312 22.3 %428 27.5 %503 30.4 %
Other Activities(1)
(505)(127)(121)(118)(139)(498)(173)(118)(111)(96)
Total1,687 15.4 %259 10.1 %842 30.9 %335 12.0 %251 8.8 %1,378 14.2 %56 2.4 %308 13.4 %483 19.4 %531 20.9 %
Less: Net Earnings (Loss) Attributable to NCI for Engineered Materials(3)(2)(2)— — — — — — 
Less: Net Earnings (Loss) Attributable to NCI for Acetyl Chain— 
Operating Profit (Loss) Attributable to Celanese Corporation1,683 15.4 %256 10.0 %844 31.0 %334 11.9 %249 8.7 %1,370 14.2 %54 2.3 %306 13.3 %481 19.3 %529 20.8 %
Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation
Engineered Materials1,086 17.7 %121 8.6 %693 45.4 %160 10.1 %112 6.9 %429 10.7 %25 2.0 %114 12.3 %166 17.5 %124 13.6 %
Acetyl Chain1,102 22.6 %262 22.2 %272 22.3 %292 23.7 %276 22.1 %1,439 25.1 %202 17.8 %310 22.2 %426 27.3 %501 30.3 %
Other Activities(1)
(505)(127)(121)(118)(139)(498)(173)(118)(111)(96)
Total1,683 15.4 %256 10.0 %844 31.0 %334 11.9 %249 8.7 %1,370 14.2 %54 2.3 %306 13.3 %481 19.3 %529 20.8 %
Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation
Engineered Materials87 45 12 20 10 207 35 70 53 49 
Acetyl Chain132 33 33 32 34 143 30 34 39 40 
Other Activities(1)
34 28 (1)12 
Total253 106 46 58 43 362 66 108 93 95 
Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation
Engineered Materials(1)(1)— — — — — — — — 
Acetyl Chain— — — — — — — — — — 
Other Activities(1)
(68)(66)(1)(2)17 (57)25 25 24 
Total(69)(67)(1)(2)17 (57)25 25 24 
Certain Items Attributable to Celanese Corporation (Table 8)
Engineered Materials(324)34 (476)25 93 143 78 22 38 
Acetyl Chain24 27 10 10 
Other Activities(1)
186 100 33 21 32 252 151 44 32 25 
Total(114)139 (438)54 131 422 239 71 47 65 
Adjusted EBIT / Adjusted EBIT Margin
Engineered Materials848 13.8 %199 14.2 %229 15.0 %205 12.9 %215 13.2 %779 19.4 %138 11.2 %206 22.2 %224 23.6 %211 23.2 %
Acetyl Chain1,258 25.8 %300 25.4 %310 25.4 %332 26.9 %316 25.3 %1,609 28.0 %242 21.3 %349 25.0 %475 30.5 %543 32.9 %
Other Activities(1)
(353)(65)(88)(93)(107)(217)(78)(45)(53)(41)
Total1,753 16.0 %434 16.9 %451 16.6 %444 15.9 %424 14.9 %2,171 22.4 %302 12.9 %510 22.2 %646 26.0 %713 28.1 %
___________________________
(1)Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
6

Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.)
celogo.jpg
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22
(In $ millions, except percentages)
Depreciation and Amortization Expense(1)
Engineered Materials447 112 111 112 112 213 90 40 41 42 
Acetyl Chain217 54 55 54 54 211 52 53 52 54 
Other Activities(2)
27 22 
Total691 174 173 172 172 446 151 97 98 100 
Operating EBITDA / Operating EBITDA Margin
Engineered Materials1,295 21.1 %311 22.1 %340 22.3 %317 20.0 %327 20.1 %992 24.7 %228 18.4 %246 26.5 %265 28.0 %253 27.8 %
Acetyl Chain1,475 30.2 %354 30.0 %365 29.9 %386 31.3 %370 29.6 %1,820 31.7 %294 25.9 %402 28.8 %527 33.8 %597 36.1 %
Other Activities(2)
(326)(57)(81)(87)(101)(195)(69)(41)(48)(37)
Total2,444 22.3 %608 23.7 %624 22.9 %616 22.0 %596 20.9 %2,617 27.1 %453 19.3 %607 26.4 %744 29.9 %813 32.0 %
___________________________
(1)Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.
(2)Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
7

celogo.jpg
Table 3
Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22
per shareper shareper shareper shareper shareper shareper shareper shareper shareper share
(In $ millions, except per share data)
Earnings (loss) from continuing operations attributable to Celanese Corporation1,969 18.00 704 6.43 952 8.70 219 2.00 94 0.86 1,902 17.41 768 7.03 192 1.76 440 4.03 502 4.61 
Income tax provision (benefit)(790)(575)(236)(4)25 (489)(840)127 112 112 
Earnings (loss) from continuing operations before tax1,179 129 716 215 119 1,413 (72)319 552 614 
Certain Items attributable to Celanese Corporation (Table 8)
(114)139 (438)54 131 422 239 71 47 65 
Refinancing and related expenses— — — 158 (1)14 (1)104 (1)26 (1)14 (1)
Adjusted earnings (loss) from continuing operations before tax1,072 268 285 269 250 1,993 181 494 625 693 
Income tax (provision) benefit on adjusted earnings(2)
(96)(23)(11)(32)(30)(259)(24)(64)(81)(90)
Adjusted earnings (loss) from continuing operations(3)
976 8.92 245 2.24 274 2.50 237 2.17 220 2.01 1,734 15.88 157 1.44 430 3.94 544 4.99 603 5.54 
Diluted shares (in millions)(4)
Weighted average shares outstanding108.8 109.0 108.9 108.9 108.6 108.4 108.5 108.4 108.4 108.2 
Incremental shares attributable to equity awards0.6 0.5 0.5 0.4 0.6 0.8 0.7 0.7 0.7 0.7 
Total diluted shares109.4 109.5 109.4 109.3 109.2 109.2 109.2 109.1 109.1 108.9 
______________________________
(1)Includes net interest expense and certain fees related to debt issued as part of our acquisition of the M&M Business.
(2)Calculated using adjusted effective tax rates (Table 3a) as follows:
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22
Adjusted effective tax rate12 12 13 13 13 13 13 
(3)Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns.
Actual Plan Asset ReturnsExpected Plan Asset Returns
(In percentages)
Q4 '23 & 20238.1 5.2 
Q4 '22 & 2022(18.4)5.4 
(4)Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive.
8

celogo.jpg
Table 3a
Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited
Actual
20232022
(In percentages)
US GAAP annual effective tax rate(67)(34)
Discrete quarterly recognition of GAAP items(1)
(6)
Tax impact of other charges and adjustments(2)
(3)
Changes in valuation allowances, excluding impact of other charges and adjustments(3)
13 (1)
Other, includes effect of discrete current year transactions(4)(5)
64 45 
Adjusted tax rate13 
______________________________
Note: As part of the year-end reconciliation, we updated the reconciliation of the GAAP effective tax rate for actual results.
(1)Such as changes in tax laws (including US tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments.
(2)Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes.
(3)Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments.
(4)Includes tax impacts related to full-year actual tax opportunities and related costs.
(5)Includes the reversal of certain U.S. GAAP deferred tax benefits related to non-recurring internal restructuring transactions related to the M&M acquisition, to centralize ownership of intellectual property with the business and to facilitate future deployment of cash to service acquisition indebtedness. Certain benefits of the internal restructuring will be realized in future periods for adjusted earnings purposes.
9

celogo.jpg
Table 4
Net Sales by Segment - Unaudited
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22
(In $ millions)
Engineered Materials6,149 1,406 1,528 1,585 1,630 4,024 1,237 929 948 910 
Acetyl Chain4,884 1,181 1,220 1,233 1,250 5,743 1,135 1,397 1,559 1,652 
Intersegment eliminations(1)
(93)(18)(25)(23)(27)(94)(24)(25)(21)(24)
Net sales10,940 2,569 2,723 2,795 2,853 9,673 2,348 2,301 2,486 2,538 
___________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
10

celogo.jpg
Table 4a
Factors Affecting Segment Net Sales Sequentially - Unaudited
Three Months Ended December 31, 2023 Compared to Three Months Ended September 30, 2023
VolumePriceCurrencyTotal
 (In percentages)
Engineered Materials(5)(3)— (8)
Acetyl Chain— (3)— (3)

Total Company(3)(3)— (6)
Three Months Ended September 30, 2023 Compared to Three Months Ended June 30, 2023
VolumePriceCurrencyTotal
(In percentages)
Engineered Materials(1)(3)— (4)
Acetyl Chain(3)(1)(1)

Total Company(3)(1)(3)
Three Months Ended June 30, 2023 Compared to Three Months Ended March 31, 2023
VolumePriceCurrencyTotal
(In percentages)
Engineered Materials(5)— (3)
Acetyl Chain(3)— (1)

Total Company(4)— (2)
Three Months Ended March 31, 2023 Compared to Three Months Ended December 31, 2022
VolumePriceCurrencyTotal
(In percentages)
Engineered Materials34 (4)32 
Acetyl Chain10 (2)10 

Total Company19 (4)17 
________________________
(1)2022 includes the effect of the acquisition of the majority of the M&M Business.

Three Months Ended December 31, 2022 Compared to Three Months Ended September 30, 2022
VolumePriceCurrencyTotal
(In percentages)
Engineered Materials34 (1)— 33 
(1)
Acetyl Chain(9)(10)— (19)

Total Company(6)— 
Three Months Ended September 30, 2022 Compared to Three Months Ended June 30, 2022
VolumePriceCurrencyTotal
(In percentages)
Engineered Materials(1)(3)(2)
Acetyl Chain(3)(5)(2)(10)

Total Company(2)(3)(2)(7)
Three Months Ended June 30, 2022 Compared to Three Months Ended March 31, 2022
VolumePriceCurrencyTotal
 (In percentages)
Engineered Materials(3)
Acetyl Chain(6)(2)(6)

Total Company(2)(2)(2)
Three Months Ended March 31, 2022 Compared to Three Months Ended December 31, 2021
VolumePriceCurrencyTotal
 (In percentages)
Engineered Materials23 (1)29 
Acetyl Chain(3)— 

Total Company12 (1)12 
11

celogo.jpg
Table 4b
Factors Affecting Segment Net Sales Year Over Year - Unaudited
Three Months Ended December 31, 2023 Compared to Three Months Ended December 31, 2022
VolumePriceCurrencyTotal
 (In percentages)
Engineered Materials21 (8)14 
Acetyl Chain14 (11)
Total Company18 (10)
Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022
VolumePriceCurrencyTotal
(In percentages)
Engineered Materials75 (12)64 
Acetyl Chain(18)(13)
Total Company33 (16)18 
Three Months Ended June 30, 2023 Compared to Three Months Ended June 30, 2022
VolumePriceCurrencyTotal
(In percentages)
Engineered Materials75 (8)— 67 
Acetyl Chain(2)(19)— (21)
Total Company27 (15)— 12 
Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022
VolumePriceCurrencyTotal
(In percentages)
Engineered Materials80 (3)79 
Acetyl Chain(9)(13)(2)(24)
Total Company23 (8)(3)12 

Three Months Ended December 31, 2022 Compared to Three Months Ended December 31, 2021
VolumePriceCurrencyTotal
 (In percentages)
Engineered Materials67 17 (9)75 
Acetyl Chain(12)(14)(3)(29)
Total Company13 (5)(5)
Three Months Ended September 30, 2022 Compared to Three Months Ended September 30, 2021
VolumePriceCurrencyTotal
 (In percentages)
Engineered Materials23 25 (12)36 
Acetyl Chain(10)(5)(13)
Total Company(2)(5)
Three Months Ended June 30, 2022 Compared to Three Months Ended June 30, 2021
VolumePriceCurrencyTotal
 (In percentages)
Engineered Materials24 24 (9)39 
Acetyl Chain(5)11 (4)
Total Company14 (4)13 
Three Months Ended March 31, 2022 Compared to Three Months Ended March 31, 2021
VolumePriceCurrencyTotal
 (In percentages)
Engineered Materials20 25 (4)41 
Acetyl Chain38 (3)42 
Total Company12 32 (3)41 
12

celogo.jpg
Table 4c
Factors Affecting Segment Net Sales Year Over Year - Unaudited
Year Ended December 31, 2023 Compared to Year Ended December 31, 2022
VolumePriceCurrencyTotal
 (In percentages)
Engineered Materials54 (1)— 53 
Acetyl Chain(17)— (15)
Total Company23 (10)— 13 
Year Ended December 31, 2022 Compared to Year Ended December 31, 2021
VolumePriceCurrencyTotal
 (In percentages)
Engineered Materials33 23 (8)48 
Acetyl Chain(6)(3)(3)
Total Company11 (4)13 

13

celogo.jpg
Table 5
Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22
(In $ millions, except percentages)
Net cash provided by (used in) investing activities(134)(168)375 (163)(178)(11,141)(10,713)(143)(136)(149)
Net cash provided by (used in) financing activities(1,456)(240)(700)(447)(69)10,290 1,944 8,600 (159)(95)
Net cash provided by (used in) operating activities1,899 830 403 762 (96)1,819 541 467 495 316 
Capital expenditures on property, plant and equipment(568)(128)(131)(145)(164)(543)(143)(139)(124)(137)
Contributions from/(Distributions) to NCI(11)— (4)(6)(1)(13)(3)(3)(3)(4)
Free cash flow(1)
1,320 702 268 611 (261)1,263 395 325 368 175 
Net sales10,940 2,569 2,723 2,795 2,853 9,673 2,348 2,301 2,486 2,538 
Free cash flow as % of Net sales12.1 %27.3 %9.8 %21.9 %(9.1)%13.1 %16.8 %14.1 %14.8 %6.9 %
______________________________
(1)Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our NCI joint ventures.
14

celogo.jpg
Table 6
Cash Dividends Received - Unaudited
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22
(In $ millions)
Dividends from equity method investments157 85 25 40 217 82 27 82 26 
Dividends from equity investments without readily determinable fair values126 31 30 31 34 133 30 30 36 37 
Total283 116 37 56 74 350 112 57 118 63 
Table 7
Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22
(In $ millions)
Short-term borrowings and current installments of long-term debt - third party and affiliates1,383 1,383 1,408 1,507 1,386 1,306 1,306 977 809 860 
Long-term debt, net of unamortized deferred financing costs12,301 12,301 12,291 12,889 13,396 13,373 13,373 11,360 3,022 3,132 
Total debt13,684 13,684 13,699 14,396 14,782 14,679 14,679 12,337 3,831 3,992 
Cash and cash equivalents(1,805)(1,805)(1,357)(1,296)(1,167)(1,508)(1,508)(9,671)(783)(605)
Net debt11,879 11,879 12,342 13,100 13,615 13,171 13,171 2,666 3,048 3,387 
15

celogo.jpg
Table 8
Certain Items - Unaudited
The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:
2023Q4 '23Q3 '23Q2 '23Q1 '232022Q4 '22Q3 '22Q2 '22Q1 '22Income Statement Classification
(In $ millions)
Exit and shutdown costs89 33 21 26 52 14 29 Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net / Non-operating pension and other postretirement employee benefit (expense) income
Asset impairments15 — — 13 12 (1)— Cost of sales / Other (charges) gains, net
Impact from plant incidents and natural disasters(1)
— — — 17 17 — — — Cost of sales
Mergers, acquisitions and dispositions195 27 46 23 99 267 138 44 29 56 Cost of sales / SG&A
Actuarial (gain) loss on pension and postretirement plans69 69 — — — 80 80 — — — Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income
Legal settlements and commercial disputes12 — — — Cost of sales / SG&A / Other (charges) gains, net
(Gain) loss on disposition of businesses and assets(510)(3)(508)— (13)(1)— (12)— Gain (loss) on disposition of businesses and assets, net
Other10 — — — Cost of sales / SG&A
Certain Items attributable to Celanese Corporation(114)139 (438)54 131 422 239 71 47 65 
___________________________
(1)Primarily associated with Winter Storm Elliott.

16

celogo.jpg
Table 9
Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited
20232022
(In $ millions, except percentages)(In $ millions, except percentages)
Net earnings (loss) attributable to Celanese Corporation1,960 1,894 
Adjusted EBIT (Table 1)
1,753 2,171 
Adjusted effective tax rate (Table 3a)
%13 %
Adjusted EBIT tax effected1,595 1,889 
20232022Average20222021Average
(In $ millions, except percentages)
Short-term borrowings and current installments of long-term debt - third parties and affiliates1,383 1,306 1,345 1,306 791 1,049 
Long-term debt, net of unamortized deferred financing costs12,301 13,373 12,837 13,373 3,176 8,275 
Celanese Corporation stockholders' equity7,091 5,637 6,364 5,637 4,189 4,913 
Invested capital20,546 14,237 
Return on invested capital (adjusted)7.8 %13.3 %
Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital9.5 %13.3 %
17